Sharad A Ghamande

Research output

Research output per year 1995 2018 2020 2021 2022 2023 2024 2025

• 67 Article
• 5 Review article
• 2 Letter
• 1 Comment/debate

Research output per year

Research output per year

Search results

• 2021

  Gemogenovatucel-T (Vigil) Immunotherapy as Maintenance in Frontline Stage III/IV Ovarian Cancer (VITAL): A Randomized, Double-Blind, Placebo-Controlled, Phase 2b Trial

  Rocconi, R. P., Grosen, E. A., Ghamande, S. A., Chan, J. K., Barve, M. A., Oh, J., Tewari, D., Morris, P. C., Stevens, E. E., Bottsford-Miller, J. N., Tang, M., Aaron, P., Stanbery, L., Horvath, S., Wallraven, G., Bognar, E., Manning, L., Nemunaitis, J., Shanahan, D. & Slomovitz, B. M. & 3 others, Herzog, T. J., Monk, B. J. & Coleman, R. L., Mar 1 2021, In: Obstetrical and Gynecological Survey. 76, 3, p. 151-152 2 p.

  Research output: Contribution to journal › Comment/debate › peer-review
  1 Scopus citations